As many as 1 in 4 U.S. military veterans with the liver disease primary biliary cholangitis (PBC) may have irreversible liver scarring, or cirrhosis,…

A liver transplant with an uncle serving as a living donor successfully managed advanced progressive familial intrahepatic cholestasis type 2 (PFIC2) in a one-year-old…

With new support from the U.S. Food and Drug Administration (FDA), Galectin Therapeutics is preparing for a late-stage clinical trial to test its therapy…